Nudge is developing non-invasive ultrasound devices to modulate brain activity for neurological treatment and human enhancement. The tech stack—Python, TypeScript, Kubernetes, AWS, Terraform—reflects a software-forward hardware company, while the project list reveals heavy investment in imaging algorithms, dose prediction, and wearable form factors. Hiring spans engineering, research, and clinical operations with mid-level dominance, indicating they're scaling post-prototype but face talent scarcity in highly specialized neurotechnology roles.
Nudge develops focused ultrasound technology to treat neurological disorders and enhance cognitive function through non-invasive brain interfaces. Founded in 2024 and based in San Francisco, the company operates across preclinical research, clinical trials, and device engineering. Active projects include imaging algorithms for ultrasound brain visualization, miniaturized wearable phased-array prototypes, and translational work moving laboratory neuromodulation findings into human clinical settings. The core technology combines acoustic simulation, MRI pulse sequencing, and ultrasound physics to deliver targeted brain stimulation.
Nudge develops non-invasive focused ultrasound devices to modulate brain activity for treating neurological disorders and enhancing human cognitive function.
Python, TypeScript, Kubernetes, AWS, Terraform, GCP, and Siemens tools. The stack emphasizes cloud infrastructure and imaging software for ultrasound neuromodulation research.
Other companies in the same industry, closest in size